CYDY

CytoDyn (QB) Stock Price

2.645
-0.025 (-0.94%)
2.645
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.025 -0.94% 2.645 12:39:01
Open Price Low Price High Price Close Price Previous Close
2.59 2.57 2.66 2.67
Bid Price Ask Price Spread News
2.64 2.65 0.01 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,298 1,203,394 $ 2.6035 $ 3,133,081 3,206,346 0.261 - 10.01
Last Trade Time Type Quantity Stock Price Currency
12:39:01 100 $ 2.645 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.49B 569.32M 302.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
26.70M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Date Time Source News Article
11/30/202008:35InvestorsHub NewsWireCompanies on the Frontline, Helping Us Through the Pandemic
11/16/202016:57Edgar (US Regulatory)Current Report Filing (8-k)
11/11/202009:29InvestorsHub NewsWireVaycaychella; the Rise of World Series of Golf, Inc...
10/26/202019:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/26/202019:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/09/202008:32Edgar (US Regulatory)Quarterly Report (10-q)
10/02/202018:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.64992.692.542.641,577,329-0.0049-0.18%
1 Month2.502.811.632.392,893,5610.1455.8%
3 Months4.815.151.633.023,170,678-2.17-45.01%
6 Months3.0110.011.634.415,537,796-0.365-12.13%
1 Year0.294910.010.2613.305,447,0512.35796.91%
3 Years0.59510.010.05522.942,077,7522.05344.54%
5 Years0.8810.010.05522.791,339,4791.77200.57%

CytoDyn (QB) Description

CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology.
Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 17:54:02